AR and hepatocellular carcinoma: Previous reports have suggested that activation of androgen/AR signaling has a positive effect on the initiation and progression of various cancer cells, including prostate cancer, renal cell carcinoma [27], bladder cancer [28], and hepatocellular carcinoma [29].